DTPa-IPV/Hib vaccine

BIOLOGICAL2 trials

Sponsors

GlaxoSmithKline

Conditions

Acellular PertussisDiphtheriaHaemophilus Influenzae Type bHepatitis BPoliomyelitisTetanus

Phase 3

Safety of DTPa-IPV/Hib & DTPa-HBV-IPV/Hib, Followed by DTPa-IPV/Hib Vaccine in Infants Who Received Hepatitis B Vaccine

CompletedNCT00325143

GlaxoSmithKlineAcellular Pertussis, Diphtheria, Haemophilus Influenzae Type b +2

Start: 2003-12-01End: 2007-02-01Updated: 2018-06-06

Immunogenicity and Safety of Primary and Booster Vaccination With DTPa-HBV-IPV/Hib Vaccine

CompletedNCT00880477

GlaxoSmithKlineHepatitis B

Start: 2001-01-31End: 2002-11-30Updated: 2016-09-07